RapidRona Self-Collection COVID-19 Kit is Awarded an Emergency Use Authorization from the FDA

Business Wire


CHICAGO--(BUSINESS WIRE)--RapidRona, a technology-enabled medical device company, announced today it has received Emergency Use Authorization (EUA) from the FDA for its SARS-CoV-2 sample self-collection kit. The Chicago-based company is focused on delivering convenience, ease-of-use, and guaranteed turnaround times for in vitro diagnostic testing for COVID-19 as the pandemic runs into flu season, testing shortages continue, and lead times among the largest testing labs increase. RapidRona lever

Full Article